WalshTJ, PizzoA.Treatment of systemic fungal infections: Recent progress and current problems. Eur J Clin Microbiol Infect Dis1988; 7:460–475.
2.
DaviesSF. An overview of pulmonary fungal infections. Clin Chest Med1987;8:495–512.
3.
Drugs for treatment of fungal infections. Medical Letter on Drugs and Therapeutics1990;32:57–60.
4.
RichardsonK, MarriottMS. Antifungal agents. Ann Rep Med Chem1987;22:159–167.
5.
BodeyGP. Topical and systemic antifungal agents. Med Clin North Am1988;72:637–659.
6.
SandeMA, MandellGL. Antifungal and antiviral agents. In: GilmanAG, GoodmanLS, RallTW, MuradF, editors. The pharmacological basis of therapeutics. 7th ed. New York: Macmillan, 1985:1219–1239.
7.
BennettJE. Antifungal agents. In: MandellGL, DouglasRGJr., BennettJE, editors. Principles and practice of infectious diseases. 2nd ed. New York: John Wiley & Sons, 1985:263–270.
8.
UtzJP. Chemotherapy of the systemic mycoses. Med Clin North Am1986;66:221–230.
9.
ZugerA, LouieE, HolzmanRS, SimberkoffMS, RallalJJ. Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Ann Intern Med1986;104:234–240.
10.
DismukesWE, StammAM, GraybillJR, . Treatment of systemic mycoses with ketoconazole: Emphasis on toxicity and clinical response in 52 patients. Ann Intern Med1983;98:13–20.
11.
Mycoses Study Group. Treatment of blastomycosis and histoplasmosis with ketoconazole. Ann Intern Med1985;103:861–872.
12.
Fluconazole. Medical Letter on Drugs and Therapeutics1990;32:50–52.
13.
ByrneWR, WajszczukCP. Cryptococcal meningitis in the acquired immunodeficiency syndrome (AIDS): Successful treatment with fluconazole after failure of amphotericin B. Ann Intern Med1988;108:384–385.
14.
GrantSM, ClissoldSP. Itraconazole: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Drugs1989;37:310–344.
15.
SaksenaAK, GirijavallabhanVM, CooperAB, LoebenbergD.Recent advances in antifungal agents. Ann Rep Med Chem1989;24:111–120.
16.
BeckerJM, MarcusS, TullockJ, . Use of the chitin-synthesis inhibitor nikkomycin to treat disseminated candidiasis in mice. J Infect Dis1988;157:212–213.
17.
TraxlerP, ToschW, ZakO.Papulacandins—Synthesis and biological activity of papulacandin B derivatives. J Antibiot (Tokyo)1987;40:1146–1164.
18.
YamaguchiH, HirataniT, BabaM, OsumiM.Effect of aculeacin A on reverting protoplasts of Candida albicans. Microbiol Immunol1987;31:625–638.